Onconetix, Inc. (ONCO): R&D Expense
$154.4K
Year ended 2024-12-31
-51.2%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $154.4K | -92.1% | 2025-06-02, From 2024-01-01 |
| 2023-12-31 | $1.95M | -52.8% | 2025-06-02, From 2023-01-01 |
| 2022-12-31 | $4.13M | +211.7% | 2024-04-11, From 2022-01-01 |
| 2021-12-31 | $1.33M | n/a | 2023-03-09, From 2021-01-01 |